US-based Sequel Med Tech has introduced its Tidepool-powered twiist automated insulin delivery (AID) system across the country.

A major wrongful death lawsuit has been filed alleging defects in Abbott Laboratories' (NYSE:ABT) FreeStyle Libre 3 and Libre 3 Plus glucose monitoring systems. The claim links the products to seven ...

Tandem Diabetes Care (NASDAQ:TNDM) executives discussed recent operating performance and a broad set of strategic initiatives ...

For five years, everything went seamlessly, but in November 2025, Newton noticed that Kramer was extremely thirsty, ...

Management expects 2026 to be its second consecutive year of adjusted EPS growth.

Abbott Laboratories is back in focus after several research houses reset their price targets, with some cuts in the US$5 to ...

Theranica, a neuromodulation therapeutics company advancing clinically validated, drug-free treatments for idiopathic pain conditions and setting a new standard of care in migraine with REN-based ...

I mean there are a number of things which makes us excited going into 2026 as well because this really underpins and gives us the momentum that we were looking for. And I'll start, were we surprised?

Tandem Diabetes Care, Inc. delivered strong Q4 '25 results, with revenue and gross margin beats driving a 32% stock surge.

Full launch of twiist™ AID system powered by Tidepool brings first-ever combination of personalized insulin automation, innovative delivery technology, and CGM interoperability to type 1 diabetes mana ...

Saputo Cheese has recalled certain cottage cheese products sold under Walmart's house brand, Great Value, the Food and Drug Administration announced.